Keywords: تومور ناهمگونی; Quantitative imaging; tumor heterogeneity; translational research; oncology; CT; computed tomography; CTTA; computed tomography texture analysis; MDT; multidisciplinary team; NSCLC; non-small cell lung cancer; PACS; picture archiving and communicating s
مقالات ISI تومور ناهمگونی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: تومور ناهمگونی; Biomarkers; Classification; Convolutional Neural Network; Deep learning; Digital pathology imaging; Tumor heterogeneity;
Keywords: تومور ناهمگونی; Single-cell analysis; Tumor heterogeneity; Subclone phylogeny; Cell identity; Tumor ecosystem; Correlation analysis;
Keywords: تومور ناهمگونی; Circulating tumor cells; Colorectal cancer; Liquid biopsy; RAS; Tumor heterogeneity;
Keywords: تومور ناهمگونی; Multiclonal tumor origin; Polyclonal; Clonality; Tumor heterogeneity; Tumor initiation; X chromosome inactivation;
Keywords: تومور ناهمگونی; Biomarkers; Tumor heterogeneity; RNA sequencing; Autopsy; Immune-related markers; RET fusion;
Keywords: تومور ناهمگونی; Cancer; Liquid biopsy; Circulating tumor cells; Precision therapy; Prognostic biomarker; Predictive biomarker; Early cancer detection; Tumor heterogeneity;
Keywords: تومور ناهمگونی; Tumor heterogeneity; Multidrug resistance; Self-induced; Mitochondria-dependent apoptosis; Reactive oxygen species, lung metastasis;
Keywords: تومور ناهمگونی; Ligand-functionalized liposomes; Dual-functionalized liposomes; EPR effect; Tumor heterogeneity; Targeted therapy; Nanomedicine;
Keywords: تومور ناهمگونی; BRCA1/2; Breast cancer; Cancer stem cells; Estrogen receptors; HER2; Noncoding RNAs; Triple-negative breast cancer; Tumor heterogeneity;
Keywords: تومور ناهمگونی; Individualized medicine; Pancreatic cancer; Chemograms; Molecular signatures; Drug sensitivity; Tumor heterogeneity;
Keywords: تومور ناهمگونی; MUC; Tumor heterogeneity; Lung cancer; Diagnosis; Therapy;
Keywords: تومور ناهمگونی; Kidney; Tumor heterogeneity; Renal cell carcinoma; Clonal evolution; Targeted therapy; Precision immuno-oncology;
Keywords: تومور ناهمگونی; Tumor heterogeneity; Precision medicine; Genetic variations; Cancer; Drug resistance; Biomarker;
Keywords: تومور ناهمگونی; Ultra-deep sequencing; Oral squamous cell carcinoma; Field cancerization; Recurrence; Tumor heterogeneity; Subclonal structure; Second field tumor;
Keywords: تومور ناهمگونی; Colorectal cancer; Next-generation sequencing; Tumor cellularity; Tumor heterogeneity; Chemotherapy;
Keywords: تومور ناهمگونی; Renal cell carcinoma; Tumor heterogeneity; Next-generation sequencing;
Keywords: تومور ناهمگونی; Androgen receptor; Castration-resistant prostate cancer; Stress response; Survival pathways; Tumor heterogeneity; Phenotypic plasticity;
Keywords: تومور ناهمگونی; DNA methylation; Tumor heterogeneity; Cancer; Molecular diagnostics; Epigenetics;
Keywords: تومور ناهمگونی; ADCC; antibody-dependent cell-mediated cytotoxicity; AKT; protein kinase B; ATP; adenosine triphosphate; cfDNA; circulating free DNA; CISH; chromogenic in-situ hybridization; CTC; circulating tumor cells; EGFR; epithelial growth factor receptor; EMT; epit
Keywords: تومور ناهمگونی; Molecular targeting; Fluorescence quenching; Optical imaging; Liposomes; Tumor heterogeneity;
Keywords: تومور ناهمگونی; Carbon ion radiotherapy; Relative biological effectiveness (RBE); Tumor heterogeneity; Prostate tumor12C, carbon ions; CI, confidence interval; CSC, cancer stem cells; FREDOM, 19F-pulse burst saturation recovery; HF, hypoxic fraction; LET, linear energy t
Keywords: تومور ناهمگونی; Circulating tumor cells; Tumor heterogeneity; Single cell sequencing; Tumor evolution; Gene mutation;
Keywords: تومور ناهمگونی; Thyroid cancer; Iodine-refractory; Tumor heterogeneity; Somatostatin receptor; Positron emission tomography; Theranostic
Keywords: تومور ناهمگونی; Active surveillance; Diagnosis; Nephrectomy; Renal biopsy; Small renal masses; Tumor heterogeneity
Keywords: تومور ناهمگونی; Ovarian serous carcinoma; Tumor heterogeneity; Metastases; Quantitative PCR; Chemotherapy response; Survival
Keywords: تومور ناهمگونی; BBB; blood-brain barrier; BRCA; breast cancer associated; ER; estrogen receptor; CTC; circulating tumor cell; ctDNA; circulating tumor DNA; DRFI; distant recurrence-free interval; DTC; disseminated tumor cell; EMT; epithelial-to-mesenchymal transition;
Keywords: تومور ناهمگونی; Tumor heterogeneity; Next-generation sequencing; Targeted therapy; Biomarkers;
Keywords: تومور ناهمگونی; Nanomedicine; Tumor heterogeneity; Tumor microenvironment; pH; Hypoxia; Matrix metalloproteinases;
Keywords: تومور ناهمگونی; Pretargeting; Tumor heterogeneity; Nanoparticles; Cancer targeting; Bispecific proteins; Drug delivery;
Keywords: تومور ناهمگونی; mathematical model; clinical application; resistance level; tumor heterogeneity; cell density; metastasis
Keywords: تومور ناهمگونی; tumor heterogeneity; resistance; personalized medicine; biomarker; co-clinical trial
Keywords: تومور ناهمگونی; BRAFV600; Melanoma; Drug resistance; MAPK; PI3K/AKT; Tumor heterogeneity; Combination therapy;
Keywords: تومور ناهمگونی; Patient-derived xenografts; Acidic tumor microenvironment; Cancer-stromal interactions; Extracellular matrix; Tumor heterogeneity; Cancer-associated fibroblasts; Regulatory immune cells; Acidic culture conditions;
Keywords: تومور ناهمگونی; Tumor heterogeneity; Drug distribution; Resistance;
Keywords: تومور ناهمگونی; Cancer immunotherapy; Personalized medicine; Tumor antigens; Predictive biomarkers; Tumor heterogeneity; Adoptive T cell therapy;
Keywords: تومور ناهمگونی; Breast cancer; Cancer stem cells; Epithelial-to-mesenchymal transition; Tumor heterogeneity; Tumor centre; Tumor margin; Snail; Slug; Twist; Zeb1;
Keywords: تومور ناهمگونی; Genome sequencing; Systems biology; Signaling network; Cancer evolution; Tumor heterogeneity; Tumor clone; Drug resistance; Early-warning signal; Personalized medicine;
Keywords: تومور ناهمگونی; Clonal evolution; Tumor heterogeneity; Cancer;
Keywords: تومور ناهمگونی; Next-generation sequencing; Cancer genomics; Transcriptomics; Chromosomal conformation sequencing; Bioinformatics; Tumor heterogeneity;
Keywords: تومور ناهمگونی; Whole-genome sequencing; Exome sequencing; RNA-Seq; Bioinformatics; FFPE; Tumor heterogeneity; Clinical applications;
Keywords: تومور ناهمگونی; Paraneoplastic syndrome; Ovarian cancer; Phantom hCG; Clinical trial; Tumor heterogeneity; β-hCG heterophilic antibody
Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma
Keywords: تومور ناهمگونی; NSCLC; Multiple lung cancer; Next-generation sequencing; Clonality; Tumor heterogeneity;
Organoids: An intermediate modeling platform in precision oncology
Keywords: تومور ناهمگونی; Organoids; 3D culture technology; Precision oncology; Cancer; Tumor heterogeneity;
Hétérogénéité moléculaire des mésothéliomes pleuraux malins
Keywords: تومور ناهمگونی; Cancer thoracique; Mésothéliome pleural malin; Altération moléculaire; Hétérogénéité tumorale; Génomique; Médecine de précision; Thoracic cancer; Malignant pleural mesothelioma; Molecular alteration; Tumor heterogeneity; Genomic; Precision med
Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment
Keywords: تومور ناهمگونی; Castration resistant prostate cancer; Tumor heterogeneity; Androgen receptor; Treatment resistance; Predictive biomarkers;
Capturing tumor heterogeneity and clonal evolution in solid cancers using circulating tumor DNA analysis
Keywords: تومور ناهمگونی; Cell-free DNA; Circulating tumor DNA; Clonal evolution; Tumor heterogeneity; Treatment resistance; cfDNA; cell-free DNA; ctDNA; circulating tumor DNA;
Molecular radiobiologyTumor heterogeneity determined with a γH2AX foci assay: A study in human head and neck squamous cell carcinoma (hHNSCC) models
Keywords: تومور ناهمگونی; γH2AX foci; Tumor heterogeneity; Biomarker; Radiosensitivity;
PhyloOncology: Understanding cancer through phylogenetic analysis
Keywords: تومور ناهمگونی; Tumor heterogeneity; Cancer stratification; Clonal evolution; Tumor trees; Cancer types;
Intratumoral heterogeneity of macrophages and fibroblasts in breast cancer is associated with the morphological diversity of tumor cells and contributes to lymph node metastasis
Keywords: تومور ناهمگونی; Breast cancer; Tumor microenvironment; Macrophage; Fibroblast; Tumor heterogeneity; Metastasis;